Tit - bits

When this report is being made the SGX NIFTY was seen at 14185.50 up 104.50 points. However, when NIFTY50 has a P/E Ratio of 38.55, it does not makes much sense to stay put on the long side of the board. 

Therefore, use all the intraday rise in the markets to eixt your long positions or stay light on the long side of the game. 

#Sell the shares of Biocon Ltd (Rs. 382.70) near the CMP for short term targets of Rs.321/319. SL: Rs.397.

Last year Biocon's CMD Kiran Mazumder - Shaw hinted that, in all likelihood its Covid-19 vaccine will be ready by June, 2021. This gave legs to the share price. However, recently a research report showed that most of vaccine makers would not be making too much money, through Covid - 19 antidote sale. The effort would be basically pegged on humanitarian grounds. 

#Join my CROREPATI SCHEME to get such early INFORMATION or ALERTS on your holdings, to maximise your chances of getting good returns from investing in equities.  With a small investment of around Rs.2 (two) lakhs you can become a multi- millionaire, through proper planning and taking aid from a source - based - news - pool and analysis. 

For more details please ping me at: suman2005s@rediffmail.com or sumanm2007s@gmail.com. 

Kindly note this is not a PMS service, as you have act on my suggestions. 

#Sell the shares of Vodafone Idea Ltd (Rs.11.75) near the CMP for short term target of Rs. 8. 

According to a report published in ET, the net worth of the loss-making Vodafone Idea Cellular (formerly Idea Cellular Ltd) is a negative ₹26,699.8 crore. The telecom company has never posted a profit since its formation through the merger of Vodafone India and Idea Cellular in August 2018, and has been rapidly losing subscribers. In such a situation it is no point of holding the scrip at such a high price, especially when the P/E of Nifty is at around 38.55, way above the equilibrium levels.